Technical Analysis: Know The Short Term Support Level on Revance Therapeutics, Inc. (RVNC)

Revance Therapeutics, Inc. (RVNC) has seen some recent activity in the stock market and its stock closed at $26.01 yesterday. Investors are starting to take interest of RVNC as the stock traded as high as $26.50 and as low as $25.04 in the last trading day.

Revance Therapeutics, Inc. (RVNC) average trading volume is 602.00K. However, in the last trading day Revance Therapeutics, Inc. (RVNC) exchanged 488,297 shares. The First downside support level on RVNC is $25.87 and the First resistance level on RVNC is $34.30. RVNC 50 day moving average is $26.98 and RVNC two hundred day moving average is $23.84.

Revance Therapeutics, Inc. (RVNC) recent performance has been indicated by the recent movement in RVNC stock. RVNC has performed 3.46% over the past 30 days, RVNC has performed 10.78% over the past quarter and RVNC has shown 65.77% over the past 12 months. Revance Therapeutics, Inc. (RVNC) has a 12 month range of $11.78 to $34.62. Revance Therapeutics, Inc. (RVNC) is trading 120.80% from its 12 month low and -24.87% from its 12 month high. Revance Therapeutics, Inc. (RVNC) is showing a 8.12% short float showing the amount short in the float.

RVNC has 54.26M shares outstanding and 53.91M shares in the float. Revance Therapeutics, Inc. (RVNC) currently has a market cap of $1.62B and income of -209.30M. The EPS next quarter for RVNC is -1.03 and projected EPS next year is 18.30%. The market cap of Revance Therapeutics, Inc. (RVNC) at $1.62B represents how many Investors own shares of RVNC and is calculated off the last price ($26.01) of RVNC and the amount of shares outstanding (54.26M) with Revance Therapeutics, Inc. (RVNC).

Revance Therapeutics, Inc. (RVNC) has aggregate cash (mrq) of 494.04M, aggregate cash per share (mrq) of 7.49, aggregate debt of RVNC is at 201.96M and aggregate debt/equity (mrq) is 78.98. . Revance Therapeutics, Inc. (RVNC) operating cash flow (ttm) is -125.96M, RVNC leveraged free cash flow (ttm) is -102.9M.

RVNC is trading 0.70% above (bullish) its SMA20, -4.27% below (bearish) its SMA50 and 14.06% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...